Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study

Trends in Cardiovascular Medicine

Volumn 20, Issue 3, 2010, Pages 90-95

  Fox, Caroline S ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY DISEASE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; GENETIC TRAIT; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 78649895347     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.08.001     Document Type: Review

References (37)

1. American Heart Association. (2010) Heart disease and stroke statistics-2008 update. Dallas, Texas: American Heart Association.
2. Brand F.N., Abbott R.D., Kannel W.B. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989, 38:504-509.
3. Cowie C.C., Rust K.F., Byrd-Holt D.D., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006, 29:1263-1268.
4. Cushman W.C., Evans G.W., Byington R.P., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585.
5. Dawber T.R., Meadors G.F., Moore F.E. Epidemiologic approaches to heart disease: the Framingham study. Am J Public Health 1951, 41:279-286.
6. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
7. Dupuis J., Langenberg C., Prokopenko I., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42:105-116.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
9. Fox C.S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 2004, 292:2495-2499.
10. Fox C.S., Sullivan L., D'Agostino R.B., et al. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 2004, 27:704-708.
11. Fox C.S., Pencina M.J., Meigs J.B., et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006, 113:2914-2918.
12. Fox C.S., Coady S., Sorlie P.D., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115:1544-1550.
13. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
14. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
15. Ginsberg H.N., Elam M.B., Lovato L.C., et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010, 362:1563-1574.
16. Kahn R., Alperin P., Eddy D., et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010, 375:1365-1374.
17. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34.
18. Kannel W.B., Feinleib M., McNamara P.M., et al. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979, 110:281-290.
19. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
20. Levitzky Y.S., Pencina M.J., D'Agostino R.B., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008, 51:264-270.
21. Meigs J.B., D'Agostino R.B., Wilson P.W., et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997, 46:1594-1600.
22. Meigs J.B., Cupples L.A., Wilson P.W. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 2000, 49:2201-2207.
23. Meigs J.B., Panhuysen C.I., Myers R.H., et al. A genome-wide scan for loci linked to plasma levels of glucose and HbA (1c) in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 2002, 51:833-840.
24. Meigs J.B., Nathan D.M., D'Agostino R.B., et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25:1845-1850.
25. Meigs J.B., Manning A.K., Fox C.S., et al. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet 2007, 8(Suppl 1):S16.
26. Meigs J.B., Shrader P., Sullivan L.M., et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008, 359:2208-2219.
27. Mokdad A.H., Bowman B.A., Ford E.S., et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-1200.
28. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 1999, 282:1523-1529.
29. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
30. Preis S.R., Pencina M.J., Hwang S.J., et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009, 120:212-220.
31. Preis S.R., Hwang S.J., Coady S., et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009, 119:1728-1735.
32. Prokopenko I., Langenberg C., Florez J.C., et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet 2009, 41:77-81.
33. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
34. Splansky G.L., Corey D., Yang Q., et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007, 165:1328-1335.
35. Tirosh A., Shai I., Tekes-Manova D., et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005, 353:1454-1462.
36. Wilson P.W., D'Agostino R.B., Parise H., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072.
37. Wilson P.W., Meigs J.B., Sullivan L., et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007, 167:1068-1074.